Fuji Medical Systems USA of Stamford, CT, entered the market for dry laser printers at last month's Radiological Society of North America meeting with FM-DP L, a new printer designed for centralized radiology departments with heavy work-flow
Fuji Medical Systems USA of Stamford, CT, entered the market for dry laser printers at last month's Radiological Society of North America meeting with FM-DP L, a new printer designed for centralized radiology departments with heavy work-flow requirements. Fuji claims that the unit is the fastest laser printer on the market, with a throughput of 130 14 x 17-inch films an hour.
FM-DP L is based on Fuji's patented semiconductor laser exposure and thermal development processes. It also features a dual film drawer option that allows it to print different film sizes from different imaging modalities. Another highlight is its use of standard 110-volt power, making it easy to site.
The printer is Fuji's first dry laser offering and will join other dry printers in Fuji's arsenal that use nonlaser development processes. The product is to be available in the second quarter of 1999 and will compete with dry laser offerings from Eastman Kodak of Rochester, NY, and Sterling Diagnostic Imaging of Greenville, SC.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.